48 related articles for article (PubMed ID: 28976447)
1. The malignant transformation of endometriosis: Is there a left lateral predisposition of ovarian clear cell and endometrioid carcinomas?
McMullan JC; Graham MJ; Craig EF; McCluggage WG; Hunter DH; Feeney L
Eur J Surg Oncol; 2024 Jun; 50(6):108247. PubMed ID: 38522332
[TBL] [Abstract][Full Text] [Related]
2. Endometriosis-associated ovarian cancer: a different clinical entity.
Leone Roberti Maggiore U; Bogani G; Paolini B; Martinelli F; Chiarello G; Spanò Bascio L; Chiappa V; Ferrero S; Ditto A; Raspagliesi F
Int J Gynecol Cancer; 2024 Jun; 34(6):863-870. PubMed ID: 38531540
[TBL] [Abstract][Full Text] [Related]
3. Comparison of surgical and oncologic outcomes in patients with clear cell ovarian carcinoma associated with and without endometriosis.
Charatsingha R; Hanamornroongruang S; Benjapibal M; Therasakvichya S; Jaishuen A; Chaopotong P; Srichaikul P; Jareemit N
Arch Gynecol Obstet; 2021 Dec; 304(6):1569-1576. PubMed ID: 34023979
[TBL] [Abstract][Full Text] [Related]
4. PURE vs. mixed clear cell ovarian carcinomas: Is there any impact on survival?
Güzel D; Terek C; Besler A; Serin G; Önal Z; Akman L; Göker E; Ali Şanli U; Zekioğlu O; Özdemir N; Özsaran A; Yildirim N
Eur J Obstet Gynecol Reprod Biol; 2024 May; 296():321-326. PubMed ID: 38518487
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma.
Itamochi H; Kigawa J; Terakawa N
Cancer Sci; 2008 Apr; 99(4):653-8. PubMed ID: 18377417
[TBL] [Abstract][Full Text] [Related]
6. Clear cell carcinomas of the mullerian system: does the pathogenesis vary depending on their nuclear grade and their association with endometriosis? An immunohistochemical analysis.
Alduaij A; Hansen K; Karim TA; Zhang C; Lomme MM; Sung CJ; Lawrence WD; Quddus MR
Patholog Res Int; 2012; 2012():674748. PubMed ID: 23213623
[TBL] [Abstract][Full Text] [Related]
7. Informing women with endometriosis about ovarian cancer risk.
Kvaskoff M; Horne AW; Missmer SA
Lancet; 2017 Dec; 390(10111):2433-2434. PubMed ID: 29208299
[No Abstract] [Full Text] [Related]
8. Origin of clear cell carcinoma: nature or nurture?
Kolin DL; Dinulescu DM; Crum CP
J Pathol; 2018 Feb; 244(2):131-134. PubMed ID: 29178260
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics and prognosis of ovarian clear cell carcinoma: a 10-year retrospective study.
Zhu C; Zhu J; Qian L; Liu H; Shen Z; Wu D; Zhao W; Xiao W; Zhou Y
BMC Cancer; 2021 Mar; 21(1):322. PubMed ID: 33766002
[TBL] [Abstract][Full Text] [Related]
10. Prognostic importance of atypical endometriosis with architectural hyperplasia versus cytologic atypia in endometriosis-associated ovarian cancer.
Ñiguez Sevilla I; Machado Linde F; Marín Sánchez MDP; Arense JJ; Torroba A; Nieto Díaz A; Sánchez Ferrer ML
J Gynecol Oncol; 2019 Jul; 30(4):e63. PubMed ID: 31074246
[TBL] [Abstract][Full Text] [Related]
11. Clear cell carcinoma of the ovary: Clinicopathologic features and outcomes in a Chinese cohort.
Tang H; Liu Y; Wang X; Guan L; Chen W; Jiang H; Lu Y
Medicine (Baltimore); 2018 May; 97(21):e10881. PubMed ID: 29794794
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes of patients with clear cell and endometrioid ovarian cancer arising from endometriosis.
Paik ES; Kim TJ; Choi CH; Kim BG; Bae DS; Lee JW
J Gynecol Oncol; 2018 Mar; 29(2):e18. PubMed ID: 29400011
[TBL] [Abstract][Full Text] [Related]
13. Is the presence of endometriosis associated with a survival benefit in pure ovarian clear cell carcinoma?
Sahin H; Sari ME; Cuylan ZF; Haberal AN; Sirvan L; Coban G; Yalcin I; Güngör T; Celik H; Meydanli MM; Ayhan A
Arch Gynecol Obstet; 2018 Apr; 297(4):1005-1013. PubMed ID: 29383437
[TBL] [Abstract][Full Text] [Related]
14. Genomic Sub-Classification of Ovarian Clear Cell Carcinoma Revealed by Distinct Mutational Signatures.
Oliveira DVNP; Schnack TH; Poulsen TS; Christiansen AP; Høgdall CK; Høgdall EV
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680390
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of IGF2BP3 as a Potential Oncogene in Ovarian Clear Cell Carcinoma.
Liu H; Zeng Z; Afsharpad M; Lin C; Wang S; Yang H; Liu S; Kelemen LE; Xu W; Ma W; Xiang Q; Mastriani E; Wang P; Wang J; Liu SL; Johnston RN; Köbel M
Front Oncol; 2019; 9():1570. PubMed ID: 32083017
[TBL] [Abstract][Full Text] [Related]
16. Endometriosis does not confer improved prognosis in ovarian clear cell carcinoma: a retrospective study at a single institute.
Zhao T; Shao Y; Liu Y; Wang X; Guan L; Lu Y
J Ovarian Res; 2018 Jun; 11(1):53. PubMed ID: 29941051
[TBL] [Abstract][Full Text] [Related]
17. Demographic, Clinical, and Prognostic Factors of Ovarian Clear Cell Adenocarcinomas According to Endometriosis Status.
Schnack TH; Høgdall E; Thomsen LN; Høgdall C
Int J Gynecol Cancer; 2017 Nov; 27(9):1804-1812. PubMed ID: 28976447
[TBL] [Abstract][Full Text] [Related]
18. Cystic and adenofibromatous clear cell carcinomas of the ovary: distinctive tumors that differ in their pathogenesis and behavior: a clinicopathologic analysis of 122 cases.
Veras E; Mao TL; Ayhan A; Ueda S; Lai H; Hayran M; Shih IeM; Kurman RJ
Am J Surg Pathol; 2009 Jun; 33(6):844-53. PubMed ID: 19342944
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of ovarian clear cell carcinoma with and without endometriosis in People's Republic of China.
Ye S; Yang J; You Y; Cao D; Bai H; Lang J; Chen J; Shen K
Fertil Steril; 2014 Dec; 102(6):1656-62. PubMed ID: 25256925
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
